Transcranial Magnetic Stimulation for Word-Finding Difficulty
(CSST Trial)
Recruiting in Palo Alto (17 mi)
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of South Carolina
Disqualifiers: Dementia, Alcohol abuse, Psychiatric, others
No Placebo Group
Trial Summary
What is the purpose of this trial?This study examines the time course of activation of the left anterior temporal lobe (ATL) during lexical processing using Transcranial Magnetic Stimulation (TMS).
Eligibility Criteria
This trial is for native English speakers aged 18 to 40 who have difficulty finding words. It's not suitable for left-handed individuals, those with dementia, alcohol abuse, psychiatric or neurological disorders, traumatic brain injury, or severe vision/hearing issues that could affect task performance.Inclusion Criteria
I am a native English speaker.
I am between 18 and 40 years old.
Exclusion Criteria
Contraindication to TMS as determined by a standard TMS screening form
Contraindication to MRI as determined by a standard MRI screening form
Left-handed participants
+1 more
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Baseline Assessment
Participants undergo a structural MRI scan for TMS target localization
1 week
1 visit (in-person)
TMS and Task Performance
Participants perform lexical, semantic, and number judgment tasks with TMS applied at different time points
30 minutes per session
Multiple sessions (in-person)
Follow-up
Participants are monitored for any delayed effects of TMS and data analysis is conducted
4 weeks
Participant Groups
The study is testing how a single pulse of Transcranial Magnetic Stimulation (TMS) affects the activation timing of the left anterior temporal lobe during word processing tasks.
1Treatment groups
Experimental Treatment
Group I: TMSExperimental Treatment1 Intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Prisma Health RichlandColumbia, SC
Loading ...
Who Is Running the Clinical Trial?
University of South CarolinaLead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)Collaborator